Home
Live Updates
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results : vimarsana.com
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results
45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md., Aug. 10, 2022 /PRNewswire/ --
Related Keywords
United Kingdom ,
Chris Welsh ,
David Deuchler ,
Mary Jane Elliott ,
Doug Doerfler ,
Emma Earl Freddy Crossley ,
Panmure Gordon ,
Rupert Dearden ,
Exchange Commission ,
Maxcyte Inc ,
Prnewswire Maxcyte Inc ,
Exchange Commission On ,
Gilmartin Group ,
Nasdaq ,
Consilium Strategic Communications ,
Year Over Core Business Revenue Growth ,
Second Quarter ,
Revenue Growth Guidance ,
Flow Electroporation ,
Cell Therapy ,
Conference Call ,
Private Securities Litigation Reform Act ,
Annual Report ,
Cyte Contacts ,
Joint Corporate ,
Consolidated Statements ,
Months Ended June ,
Net Loss ,
Maxcyte ,
Eports ,
Econd ,
Uarter ,
Calf ,
Ear ,
022 ,
Inancial ,
Esults ,
vimarsana.com © 2020. All Rights Reserved.